Anne Elizabeth Borgman - 12 Oct 2022 Form 4 Insider Report for CURIS INC (CRIS)

Role
Director
Signature
/s/ Diantha Duvall, Attorney-in-fact
Issuer symbol
CRIS
Transactions as of
12 Oct 2022
Net transactions value
$0
Form type
4
Filing time
14 Oct 2022, 16:06:54 UTC
Previous filing
24 Jun 2022
Next filing
24 Jan 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRIS Non Qualified Stock Option Award $0 +25,000 $0.000000 25,000 12 Oct 2022 Common stock 25,000 $0.7300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on October 12, 2023, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on October 12, 2026, subject to Dr. Borgman's continued service on the Company's Board.